Cargando…
Prognostic Markers in Chondrosarcoma: Evaluation of Cell Proliferation and of Regulators of the Cell Cycle
Purpose. The prognosis, treatment principles and prediction of clinical outcome of patients with chondrosarcoma currently rest on histologic grading which is somewhat ambiguous due to difficulty in pathologic interpretation of this neoplasm. Immunohistochemistry, flow cytometry and oncogene/tumor su...
Autores principales: | Scully, Sean P., Layfield, Lester J., Harrelson, John M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395354/ https://www.ncbi.nlm.nih.gov/pubmed/18521206 http://dx.doi.org/10.1080/13577149778344 |
Ejemplares similares
-
Prognostic markers in smear preparations for pancreatic endocrine neoplasms: A cytomorphologic study and statistical analysis of 20 potential prognostic features
por: Layfield, Lester J., et al.
Publicado: (2016) -
Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
por: Nishida, K., et al.
Publicado: (2008) -
Identification of ZNF704 as a Novel Oncogene and an Independent Prognostic Marker in Chondrosarcoma
por: Chen, Changbao, et al.
Publicado: (2021) -
Evaluating the Role of PTH in Promotion of Chondrosarcoma Cell Proliferation and Invasion by Inhibiting Primary Cilia Expression
por: Xiang, Wei, et al.
Publicado: (2014) -
Clinical and Histopathological Prognostic Factors in Chondrosarcomas
por: Daugaard, Søren, et al.
Publicado: (1997)